Lyon Street Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-14,608
| Closed | -$1.24M | – | 48 |
|
|
2018
Q4 | $1.24M | Sell |
14,608
-255
| -2% | -$21.6K | 1.24% | 33 |
|
|
2018
Q3 | $2.55M | Sell |
14,863
-36,414
| -71% | -$6.24M | 1.58% | 17 |
|
|
2018
Q2 | $6.63M | Sell |
51,277
-14,659
| -22% | -$1.89M | 2.36% | 12 |
|
|
2018
Q1 | $6.79M | Buy |
65,936
+2,207
| +3% | +$227K | 2.19% | 14 |
|
|
2017
Q4 | $5.44M | Buy |
+63,729
| New | +$5.44M | 1.82% | 21 |
|